Lizzy Lawrence from STAT News - Journalist Profile

	Profile	Recent Articles on Subject
1	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: FDA cuts hit AI division, even as Trump invests in the technology - 6 days ago Trump administration lays off FDA employees - 7 days ago Trump administration to fire thousands at health agencies - 8 days ago STAT+: 3 key issues to watch at the FDA as Trump takes office - about 2 months ago Fixing pulse oximeters requires federal might and possible legal action, researchers say - about 2 months ago STAT+: FDA deputy commissioner Namandjé Bumpus to leave agency - 2 months ago STAT+: Supreme Court tackles case involving FDA’s oversight of flavored vapes - 3 months ago Trump taps biotech investor Jim O’Neill for HHS deputy secretary - 3 months ago STAT+: New details on a risky medical device show need for more FDA transparency, researchers say - 3 months ago STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 4 months ago STAT+: What letting RFK Jr. ‘go wild’ might mean for Trump’s FDA - 4 months ago STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 4 months ago STAT+: UnitedHealth collected billions in questionable Medicare payments, federal watchdog finds - 4 months ago Amy Abernethy, former No. 2 at FDA, outlines new company’s plans to streamline clinical research - 4 months ago Youth vaping continues its tumble from a Juul-fueled high - 6 months ago STAT+: Another suit filed against FDA over lab-developed test rule - 6 months ago STAT+: Jeff Shuren, medical devices head at FDA, to leave the agency - 7 months ago STAT+: Supreme Court’s gutting of Chevron doctrine could mean headaches for drug industry - 8 months ago STAT+: Boston Scientific to buy vascular device maker for $1.16 billion - 8 months ago STAT+: Former medical device CEO who sold fake plastic parts sentenced to 6 years in prison - 8 months ago STAT+: Device made by company J&J is buying for $13 billion clears hurdle in independent study - 11 months ago STAT+: In first big randomized trial, Abiomed’s heart pump reduced deaths in heart attack patients - 11 months ago STAT+: Johnson & Johnson to buy Shockwave Medical for $13.1 billion - 11 months ago STAT+: FDA approves TriClip for tricuspid heart valve disease, pitting Abbott against Edwards - 11 months ago STAT+: EPA restricts cancer-causing chemical used to sterilize medical devices - 12 months ago STAT+: Researchers create talking throat patch for people with voice disorders - 12 months ago STAT+: IVF doctors demand full details on fluid that grows embryos amid CooperSurgical lawsuits - 12 months ago STAT+: Former medical device CEO who sold dummy, plastic parts convicted of fraud - 12 months ago STAT+: Medical device lobby says it’s tired of waiting on Medicare to cover breakthrough devices - 12 months ago STAT+: FDA warns medical device makers about rise in fabricated data - about 1 year ago STAT+: FDA advisory panel votes in favor of Abbott’s new heart device - about 1 year ago STAT+: The FDA’s diagnostics chief, who led through Covid, has retired - about 1 year ago STAT+: Apple Watch pulse oximeter feature removed to comply with ban - about 1 year ago STAT+: An injectable gel enters the male birth control fray with early positive clinical data - about 1 year ago STAT+: Apple Watches are back on sale while federal court reviews patent suit - about 1 year ago STAT+: Philips pays $2.4 million for allegedly giving kickbacks to sleep labs - about 1 year ago STAT+: With Biden finalizing an Apple Watch ban, Apple needs to decide its future in health - about 1 year ago STAT+: 3 medtech trends to watch in 2024 - about 1 year ago STAT+: SEC charges former CEO of pain relief device company with $41 million fraud - about 1 year ago STAT+: Apple pauses sales of latest watches in the U.S. after ITC decision - about 1 year ago STAT+: Amputees have better balance, less pain after electrical stimulation, study finds - about 1 year ago STAT+: GE HealthCare CEO named chair of AdvaMed as device lobby forms new imaging division - about 1 year ago STAT+: Medtronic cancels $738 million acquisition of diabetes tech company EOFlow - about 1 year ago STAT+: How the CEO of the largest medical device accelerator molds medtech startups - over 1 year ago STAT+: FDA approves Medtronic high blood pressure device despite a negative advisory panel vote - over 1 year ago STAT+: A digital pill shows early promise in detecting opioid overdose, sleep apnea - over 1 year ago NYU radiologists tackle the challenge of making MRI machines less expensive - over 1 year ago STAT+: FDA approves high blood pressure device from ReCor Medical - over 1 year ago STAT+: Inari Medical to buy last-line amputation prevention company LimFlow - over 1 year ago STAT+: ITC recommends partial import ban of Apple Watches in Masimo patent case - over 1 year ago
2	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	Trump administration lays off FDA employees - 7 days ago Trump administration to fire thousands at health agencies - 8 days ago STAT+: Device made by company J&J is buying for $13 billion clears hurdle in independent study - 11 months ago
3	Helen Branswell STAT News Frontiers of health & medicine reporting. healthmedicinejournalism	Trump administration to fire thousands at health agencies - 8 days ago
4	Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia health policyjournalism	Trump administration to fire thousands at health agencies - 8 days ago STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 4 months ago
5	Anil Oza STAT News	Fixing pulse oximeters requires federal might and possible legal action, researchers say - about 2 months ago
6	Usha Lee McFarling STAT News	Fixing pulse oximeters requires federal might and possible legal action, researchers say - about 2 months ago
7	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 4 months ago STAT+: Supreme Court’s gutting of Chevron doctrine could mean headaches for drug industry - 8 months ago
8	Rachel Cohrs Zhang STAT News	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 4 months ago
9	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 4 months ago STAT+: Supreme Court’s gutting of Chevron doctrine could mean headaches for drug industry - 8 months ago
10	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 4 months ago